ZFP82
Zinc finger protein 82 homolog
Also known as: KIAA1948, MGC45380, ZFP82_HUMAN, ZNF545
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N141
- Gene
- ZFP82
- Ensembl
- ENSG00000181007
- Chromosome
- 19
- Canonical length
- 532 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear membrane,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
532 residues, UniProt reviewed canonical sequence.
>Q8N141|ZFP82
1 MALRSVMFSD VSIDFSPEEW EYLDLEQKDL YRDVMLENYS NLVSLGCFIS KPDVISSLEQ
61 GKEPWKVVRK GRRQYPDLET KYETKKLSLE NDIYEINLSQ WKIMERIENH GLKGLILKND
121 WESTGKIEGQ ERPQEGYFSS VKMPSEKVSS YQKRTSVTPH QRLHFVDKPY ECKECGKAFR
181 VRQQLTFHHR IHTGEKPYEC KECGMAFRQT AHLTRHQRLH SGEKLYECKE CGEAFICGAD
241 LRVHQKMHIG EKPYECKECG KAFRVRGQLT LHQRIHTGEK PYVCKECGKA FRQYAHLTRH
301 QKLNSADRLY ECKECGKAFL CGSGLRVHHK LHTGEKPYEC KECGKAFRVR QQLTLHQRIH
361 TGEKPYECKE CGKTFSRGYH LILHHRIHTG EKPYECKECW KAFSRYSQLI SHQSIHIGVK
421 PYDCKECGKA FRLLSQLTQH QSIHIGEKPY KCKECGKAFR LRQKLTLHQS IHTGEKPFEC
481 KECRKAFRLN SSLIQHLRIH SGEKPYECKE CKKAFRQHSH LTHHLKIHNV KILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFP82 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 4.7 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 4.7 nTPM
- retina: 4.7 nTPM
- epididymis: 4 nTPM
- ovary: 3.8 nTPM
- thyroid gland: 3.8 nTPM
- cerebral cortex: 3.5 nTPM
Single-cell type
- bergmann glia: 38 nCPM
- oligodendrocyte progenitor cells: 36 nCPM
- oligodendrocytes: 36 nCPM
- early primary spermatocytes: 33 nCPM
- retinal amacrine cells: 32 nCPM
- lactotrophs: 31 nCPM
Immune cell
- memory B-cell: 4.9 nTPM
- naive B-cell: 4.3 nTPM
- naive CD4 T-cell: 4 nTPM
- naive CD8 T-cell: 3.6 nTPM
- memory CD8 T-cell: 3 nTPM
- gdT-cell: 2.7 nTPM
Brain region
- cerebellum: 12 nTPM
- cerebral cortex: 9.6 nTPM
- basal ganglia: 8.9 nTPM
- hypothalamus: 8.7 nTPM
- white matter: 8.7 nTPM
- hippocampal formation: 8.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.58
- gnomAD missense Z
- 1.85
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFP82 as an antibody target. Whether an autoantibody or antibody against ZFP82 could matter depends on whether native ZFP82 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFP82 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFP82 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...